Showing results (21-30 of 137) with videos related to
Sort By:
Pageof 14
Multiple Sclerosis and Related Disorders|November 4, 2024
Prognosis of patients with multiple sclerosis associated with uveitisMarine Martin, Jean-Sébastien Vidal, Caroline Papeix, et al.Multiple Sclerosis and Related Disorders|December 1, 2019
Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disordersYsoline Beigneux, Isabelle Arnulf, Perrine Guillaume-Jugnot, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2024
Longitudinally extensive posterolateral myelitis revealing invasive CNS aspergillosis in an immunocompetent patientLina Jeantin, Delphine Leclercq, Suzanne Tran, et al.Neurology|February 6, 2025
Severe Relapse After Switching From Eculizumab to Satralizumab in Neuromyelitis Optica Spectrum DisorderElisabeth Maillart, Anne-Laure Dubessy, Natalia Shor, et al.Annals of Intensive Care|January 7, 2024
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacksEdouard Januel, Vincent Brochard, Loïc Le Guennec, et al.Multiple Sclerosis and Related Disorders|May 18, 2021
Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric studyMarine Boudot de la Motte, Céline Louapre, Caroline Papeix, et al.Journal of Neurointerventional Surgery|April 28, 2022
'Balloon pressure technique' for endovascular treatment of spinal cord arteriovenous fistulas: preliminary results in 10 casesFrédéric Clarençon, Damien Parat, Eimad Shotar, et al.Journal of Neurointerventional Surgery|August 30, 2020
Spinal epidural arteriovenous fistula embolization with ethylene vinyl alcohol (EVOH) copolymer using the Scepter Mini dual-lumen balloonFrédéric Clarençon, Eimad Shotar, Arnaud Pouvelle, et al.Multiple Sclerosis and Related Disorders|June 23, 2021
How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP)Kévin Bigaut, Mikaël Cohen, Françoise Durand-Dubief, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 2, 2026
Clinical relevance and predictors of anti-natalizumab antibodies in multiple sclerosis: A real-world retrospective cohort studyMichael Levy, Ysoline Beigneux, Thomas Roux, et al.Pageof 14